Literature DB >> 17050759

Late-life benzodiazepine use among Russian-speaking immigrants in Israel.

Richard Isralowitz1, Alex Reznik, Sofia Borkin.   

Abstract

PURPOSE: In this prospective study, we examine the reasons for benzodiazepine use among Russian-speaking elderly people in Israel, and we discuss issues related to immigrants. We provide information that can be applied to the improvement of age-related health and social services. DESIGN AND METHODS: During a 6-month period, we interviewed late-life Russian-speaking immigrants in Israeli independent living facilities to determine benzodiazepine use among such individuals.
RESULTS: Among individuals interviewed, 69% reported use; 45% of those who used the substance did so daily. Respondents aged 80 and older were more likely than those aged younger than 80 to use benzodiazepines. More men (78%) than women (67%) reported use, but we found no significant difference in a comparison of gender status and pattern of drug use. IMPLICATIONS: Although other studies of drug use show that patterns of use differ significantly among older men and women, this research indicates that gender status does not appear to influence the pattern of, and reasons for, benzodiazepine use. Additional studies are needed in order for researchers to further understand the nature and extent of benzodiazepine use. Such information should be applied to the development of policies and services that will address the quality-of-life needs of individuals who use or misuse this drug and others like it.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050759     DOI: 10.1093/geront/46.5.677

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  2 in total

1.  International spotlight: Israel.

Authors:  Allen Glicksman; Howard Litwin
Journal:  Gerontologist       Date:  2011-10-30

2.  Epidemic Use of Benzodiazepines among Older Adults in Israel: Epidemiology and Leverage Points for Improvement.

Authors:  Michael A Steinman; Marcelo Low; Ran D Balicer; Efrat Shadmi
Journal:  J Gen Intern Med       Date:  2017-05-03       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.